All Stories

  1. Needs assessment and preparedness of the primary health care network for scaling-up preventive tuberculosis treatment in 5 Brazilian capitals

    Article • PLOS One, June 2025, PLOS

    Anete Trajman

  2. Daily 800 mg versus 600 mg Efavirenz for HIV Patients Treating Tuberculosis with a Rifampicin-Based Regimen: An Open Label Randomized Controlled Trial

    Article • BioMed Research International, December 2018, Hindawi Publishing Corporation

    Anete Trajman

  3. New short regimens for latent tuberculosis treatment: safety first!

    Article • European Respiratory Journal, December 2018, European Respiratory Society (ERS)

    Anete Trajman